Mary Wang
About Mary Wang
Mary Wang is a Senior Manager of Growth Utilization at Carrum Health, with a diverse background in product management and marketing across various industries. She has held significant roles at companies such as Cleo, Bird + Stone, and The Blackstone Group, and has experience in venture capital and investment.
Current Role at Carrum Health
Mary Wang serves as the Senior Manager of Growth Utilization at Carrum Health, a position she has held since 2024. In this role, she focuses on strategies to enhance growth and utilization within the organization, leveraging her extensive background in product strategy and business operations.
Previous Experience in Product Management
Mary Wang has a diverse background in product management. She worked at Cleo as a Product Strategy & Business Operations Manager from 2020 to 2022, where she contributed to product development and operational efficiency. Prior to that, she held internships at Red Ventures and Cleo, gaining valuable experience in product management during her MBA studies.
Investment and Venture Capital Background
Mary Wang has experience in investment and venture capital. She served as an Investor Fellow at Amplifyher Ventures in 2019 and completed an internship at Pritzker Group. Her focus has been on sectors such as digital health, health and wellness, and consumer technology, where she influenced institutional investors in their hedge fund portfolios.
Educational Background
Mary Wang holds a Bachelor of Science in Commerce and Chinese from the University of Virginia, where she studied from 2009 to 2013. She furthered her education by obtaining a Master of Business Administration from The University of Chicago Booth School of Business, completing her studies from 2018 to 2020.
Leadership in Marketing and Growth
Mary Wang has held leadership roles in marketing and growth strategies. As Chief Marketing Officer at Bird + Stone from 2014 to 2017, she successfully grew a socially conscious jewelry brand with a minimal marketing budget. Most recently, she worked as a Senior Growth Manager at Sword Health from 2022 to 2024, focusing on growth strategies in a remote setting.